Drug Delivery Strategies for the Treatment of Metabolic Diseases

被引:39
|
作者
Shi, Sanjun [1 ,2 ,3 ]
Kong, Na [1 ,2 ,3 ]
Feng, Chan [1 ,2 ,3 ]
Shajii, Aram [1 ,2 ,3 ]
Bejgrowicz, Claire [1 ,2 ,3 ]
Tao, Wei [1 ,2 ,3 ]
Forokhzad, Omid C. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词
biomaterials; drug delivery; metabolic diseases; nanomedicine; LOOP INSULIN DELIVERY; ONE-POT SYNTHESIS; ORAL DELIVERY; POLYMERIC NANOPARTICLES; CONTROLLED-RELEASE; MODIFIED LEPTIN; GLUCOSE; OBESITY; INFLAMMATION; MECHANISMS;
D O I
10.1002/adhm.201801655
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Metabolic diseases occur when normal metabolic processes are disrupted in the human body, which can be congenital or acquired. The incidence of metabolic diseases worldwide has reached epidemic proportions. So far, various methods including systemic drug therapy and surgery are exploited to prevent and treat metabolic diseases. However, current pharmacotherapeutic options for treatment of these metabolic disorders remain limited and ineffective, especially reducing patient compliance to treatment. Therefore, it is desirable to exploit effective drug delivery approaches to effectively treat metabolic diseases and reduce side effects. This brief review summarizes novel delivery strategies including local, targeted, and oral drug delivery strategies, as well as intelligent stimulus-responsive drug delivery strategy, for the treatment of metabolic disorders including diabetes, obesity, and atherosclerosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Recent advances in drug delivery strategies for treatment of ovarian cancer
    Zahedi, Payam
    Yoganathan, Roshan
    Piquette-Miller, Micheline
    Allen, Christine
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (05) : 567 - 583
  • [42] Management of bone diseases: looking at scaffold-based strategies for drug delivery
    Bordone, Myriam
    Bettencourt, Ana
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (01) : 79 - 104
  • [43] Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord
    Ziemba, Alexis M.
    Gilbert, Ryan J.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [44] Strategies to improve micelle stability for drug delivery
    Lu, Yang
    Zhang, Ershuai
    Yang, Jianhai
    Cao, Zhiqiang
    NANO RESEARCH, 2018, 11 (10) : 4985 - 4998
  • [45] Enzyme responsive drug delivery systems in cancer treatment
    Shahriari, Mahsa
    Zahiri, Mahsa
    Abnous, Khalil
    Taghdisi, Seyed Mohammad
    Ramezani, Mohammad
    Alibolandi, Mona
    JOURNAL OF CONTROLLED RELEASE, 2019, 308 : 172 - 189
  • [46] Drug Delivery and Therapy Strategies for Osteoporosis Intervention
    Ma, Mingyang
    Zeng, Huiling
    Yang, Pei
    Xu, Jiabing
    Zhang, Xingwang
    He, Wei
    MOLECULES, 2023, 28 (18):
  • [47] Transdermal Drug Delivery Systems and Their Use in Obesity Treatment
    Li, Zhiguo
    Fang, Xuexun
    Yu, Dahai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [48] Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies
    Giordano, Carmen
    Albani, Diego
    Gloria, Antonio
    Tunesi, Marta
    Batelli, Sara
    Russo, Teresa
    Forloni, Gianluigi
    Ambrosio, Luigi
    Cigada, Alberto
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (12) : 836 - 850
  • [49] Advances in Biomaterials for Drug Delivery
    Fenton, Owen S.
    Olafson, Katy N.
    Pillai, Padmini S.
    Mitchell, Michael J.
    Langer, Robert
    ADVANCED MATERIALS, 2018, 30 (29)
  • [50] Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
    Zhao, Lin
    Chen, Jiamei
    Bai, Bai
    Song, Guili
    Zhang, Jingwen
    Yu, Han
    Huang, Shiwei
    Wang, Zhang
    Lu, Guanghua
    FRONTIERS IN PHARMACOLOGY, 2024, 14